1. The comparable tumour microenvironment in sporadic andNF2-related schwannomatosis vestibular schwannoma
   Grace E Gregory et al, 2023, Brain Communications CrossRef
2. Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas
   Hans-Juergen Schulten et al, 2019, PLOS ONE CrossRef
3. Gene Expression Signatures Identify Biologically Homogenous Subgroups of Grade 2 Meningiomas
   Zsolt Zador et al, 2020, Frontiers in Oncology CrossRef
4. Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma
   Kunal S. Patel et al, 2020, Journal of Neuro-Oncology CrossRef
5. Is Insulin Receptor Substrate4 (IRS4) a Platform Involved in the Activation of Several Oncogenes?
   Luis G. Guijarro et al, 2023, Cancers CrossRef
6. A gene expression signature predicts recurrence-free survival in meningioma
   Adriana Olar et al, 2018, Oncotarget CrossRef
7. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions
   Bérengère Dadone-Montaudié et al, 2018, Modern Pathology CrossRef
8. Identification of key pathways and genes in vestibular schwannoma using bioinformatics analysis
   Bo Wu et al, 2022, Experimental and Therapeutic Medicine CrossRef
9. Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors
   Mohamed El-Gewely et al, 2016, Cancers CrossRef
10. Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression
    Hans-Juergen Schulten et al, 2016, PLOS ONE CrossRef
11. Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target
    Kayleigh Bassiri et al, 2017, EBioMedicine CrossRef